Literature DB >> 23178720

Dab1 stabilizes its interaction with Cin85 by suppressing Cin85 phosphorylation at serine 587.

Bior K Bior1, Bryan A Ballif.   

Abstract

Crk and CrkL adaptors play essential neuronal positioning roles downstream of Reelin-induced Dab1 tyrosine phosphorylation. Recently we identified Cin85 to be a CrkL-SH3 binding partner from embryonic murine brain while others found Cin85 binds directly to Dab1. Here using mass spectrometry, biochemical and mutational analyses we show that Dab1 suppresses Cin85 phosphorylation at Ser587. Furthermore a Cin85 Ser587 phosphomimetic disrupts the Dab1-Cin85 complex without affecting the Cin85-CapZ complex. These data provide an early glimpse into how Cin85 phosphorylation might alter the composition of its scaffolding partners to regulate its diverse roles including vesicular trafficking, receptor endocytosis and actin remodeling.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178720      PMCID: PMC3532509          DOI: 10.1016/j.febslet.2012.10.051

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Identification of 14-3-3epsilon substrates from embryonic murine brain.

Authors:  Bryan A Ballif; Zhongwei Cao; Daniel Schwartz; Kermit L Carraway; Steven P Gygi
Journal:  J Proteome Res       Date:  2006-09       Impact factor: 4.466

2.  A mechanism for inside-out lamination in the neocortex.

Authors:  Jonathan A Cooper
Journal:  Trends Neurosci       Date:  2008-02-05       Impact factor: 13.837

3.  Controlling signal transduction with synthetic ligands.

Authors:  D M Spencer; T J Wandless; S L Schreiber; G R Crabtree
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

4.  Absence of Fyn and Src causes a reeler-like phenotype.

Authors:  Gloria Kuo; Lionel Arnaud; Priscilla Kronstad-O'Brien; Jonathan A Cooper
Journal:  J Neurosci       Date:  2005-09-14       Impact factor: 6.167

5.  A purine analog kinase inhibitor, calcium/calmodulin-dependent protein kinase II inhibitor 59, reveals a role for calcium/calmodulin-dependent protein kinase II in insulin-stimulated glucose transport.

Authors:  Nicky Konstantopoulos; Seb Marcuccio; Stella Kyi; Violet Stoichevska; Laura A Castelli; Colin W Ward; S Lance Macaulay
Journal:  Endocrinology       Date:  2006-09-28       Impact factor: 4.736

6.  Crk and Crk-like play essential overlapping roles downstream of disabled-1 in the Reelin pathway.

Authors:  Tae-Ju Park; Tom Curran
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

7.  Dual functions of Dab1 during brain development.

Authors:  Libing Feng; Jonathan A Cooper
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

8.  Regulation of the interaction of Disabled-1 with CIN85 by phosphorylation with Cyclin-dependent kinase 5.

Authors:  Yutaka Sato; Masato Taoka; Nami Sugiyama; Ken-ichiro Kubo; Takahiro Fuchigami; Akiko Asada; Taro Saito; Kazunori Nakajima; Toshiaki Isobe; Shin-ichi Hisanaga
Journal:  Genes Cells       Date:  2007-12       Impact factor: 1.891

Review 9.  Developmental anatomy of reeler mutant mouse.

Authors:  Yu Katsuyama; Toshio Terashima
Journal:  Dev Growth Differ       Date:  2009-04       Impact factor: 2.053

10.  Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons.

Authors:  Bryan A Ballif; Lionel Arnaud; William T Arthur; Deborah Guris; Akira Imamoto; Jonathan A Cooper
Journal:  Curr Biol       Date:  2004-04-06       Impact factor: 10.834

View more
  1 in total

1.  Reelin expression in human liver of patients with chronic hepatitis C infection.

Authors:  Simone Carotti; Giuseppe Perrone; Michelina Amato; Umberto Vespasiani Gentilucci; Daniela Righi; Maria Francesconi; Claudio Pellegrini; Francesca Zalfa; Maria Zingariello; Antonio Picardi; Andrea Onetti Muda; Sergio Morini
Journal:  Eur J Histochem       Date:  2017-03-17       Impact factor: 3.188

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.